Loading company…
OncoRes Medical develops intraoperative imaging technology to help surgeons detect residual tumors.
Founded in 2016 and based in Nedlands, Australia, OncoRes Medical develops a Quantitative Micro-Elastography imaging system that gives surgeons real-time information about tissue stiffness and potential residual tumors. In February 2026, it raised AUD 27 million from Brandon Capital Partners, Radar Ventures, Morgans Financial Limited, and The Table Club to support an Australian clinical trial, product development, regulatory work, and U.S. manufacturing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in